RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,739,421 | -32.4% | 801,358 | +0.9% | 0.00% | -50.0% |
| Q2 2023 | $9,975,504 | -30.6% | 794,228 | -9.0% | 0.00% | -33.3% |
| Q1 2023 | $14,368,790 | +9.0% | 872,422 | -1.1% | 0.00% | 0.0% |
| Q4 2022 | $13,181,488 | -27.9% | 882,295 | +7.9% | 0.00% | -25.0% |
| Q3 2022 | $18,294,000 | +36.7% | 817,835 | +2.4% | 0.00% | +33.3% |
| Q2 2022 | $13,383,000 | -31.2% | 798,949 | +22.8% | 0.00% | 0.0% |
| Q1 2022 | $19,464,000 | -7.4% | 650,351 | -5.0% | 0.00% | 0.0% |
| Q4 2021 | $21,018,000 | +15.8% | 684,390 | +18.8% | 0.00% | 0.0% |
| Q3 2021 | $18,158,000 | -5.0% | 575,928 | +10.3% | 0.00% | 0.0% |
| Q2 2021 | $19,104,000 | +24.4% | 522,106 | +17.6% | 0.00% | 0.0% |
| Q1 2021 | $15,355,000 | +3.8% | 444,133 | +24.8% | 0.00% | 0.0% |
| Q4 2020 | $14,791,000 | -3.0% | 355,893 | -0.6% | 0.00% | 0.0% |
| Q3 2020 | $15,249,000 | – | 358,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |